Moving Treatment of NMO Forward

2021 RNDS | A Treatment Option for NMOSDПодробнее

Selecting treatment options for NMOSDПодробнее

Neruomyelitis Optica Treatment Making Great StridesПодробнее

AQP4-IgG FACS Assay: Finding NeMO [Hot Topic]Подробнее

Approved Treatments for Neuromyelitis Optica Spectrum DisorderПодробнее

Neuromyelitis Optica and Multiple Sclerosis Differences Matter in Diagnosis and TreatmentПодробнее

How do Clinicians treat NMO?Подробнее

NMOSD Multidisciplinary Approach Webinar, 25 June 2021 - Dr. Suzan Ibrahim NooriПодробнее

New Treatments for Neuromyelitis Optica in the PipelineПодробнее

Updates in NMOSD managementПодробнее

Neuromyelitis optica: new treatments and areas of developmentПодробнее

Does spinal cord damage occur in NMO?Подробнее

205. Understanding Clinical Trials in NMO and TMПодробнее

Which Clinician Usually Diagnoses Neuromyelitis Optica Spectrum Disorder?Подробнее

Updates in the treatment of NMOSD: targeted agentsПодробнее

New Method for NMO Testing at Mayo ClinicПодробнее

Will Embryonic Stem Cell Treatments Help NMO Patients?Подробнее

Prognostic factors in NMOSD: age, ethnicity, and relapse historyПодробнее

NMOSD: Learn the Recent Advancements in Diagnosis and Treatment, 19 March 2022Подробнее